Toggle navigation
Home
About US
Committee of Administration
Role of Council
Articles of Association
Annual Report
List of MoUs Signed by Pharmexcil
Our Services
MDA/MAI Forms
Certification of Origin
Members
View Members
Trade Enquiries
Relevant Member Forms
Representations to Government
Submit Quaterly Reports
Economic & Commercial Reports
Market Information & Reports
Circulars for Members
General Information
Tenders
Members Achievements
Events
Pharmexcil Events 2025-26
Pharmexcil Events 2024-25
Pharmexcil Events 2023-24
Pharmexcil Events 2022-23
Conferences & Presentation
General Pharma Events
Tenders
Media
Pharma News Articles
Pharma in News
Global Pharma News
Country Wise
News on Counterfeit Drugs
Drug Reg./Market Reports/IPR
Photo Gallery
Video Gallery
Resource Center
Pharmexcil Study Reports
MDA
Barcode
Exemption from Barcoding
Government Schemes
Useful Information
Chemical Weapons Convention
Trade Statistics
Foreign Missions in India
Government Notifications/Circulars
Indian Misions abroad
Indian Pharma Companies
International Guidelines
Knowledge Corpus - Compiled by Dr.Appaji
List of Holidays
Market Information & Reports
Pharmexcil Research Publications
Record notes of Important Ministerial Meetings
Office Order-Internal Complaints Committee under the provisions/guidelines of Sexual Harassment of Women at Workplace
MAI Scheme
MAI Scheme
MAI Circulars
List of Beneficiaries (FMO)
Reference Dates for Calculating Eligibility Criteria (List of Countries)
FAQ's
Contact Us
Contact
Feedback
Login
Home
Home
Home
»
Govtpolicy Comments
» Viewpolicy
Back
Details
Comments Invited for Bill proposed in US Senate as Drug Safety Enhancement Act, 2011-An amendment to Federal Food, Drug and Cosmetic Act edit
Click here to open
